سوق أجهزة الصدمات في الشرق الأوسط وأفريقيا - اتجاهات الصناعة وتوقعاتها حتى عام 2030

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE MIDDLE EAST AND AFRICA (MEA)TRAUMA DEVICES MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 MIDDLE EAST AND AFRICA (MEA)TRAUMA DEVICES MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S FIVE FORCES MODEL

6 INDUSTRY INSIGHTS

6.1 MICRO AND MACRO ECONOMIC FACTORS

6.2 PENETRATION AND GROWTH PROSPECT MAPPING

6.3 KEY PRICING STRATEGIES

6.4 INTERVIEWS WITH SPECIALIST

6.5 ANALYIS AND RECOMMENDATION

7 COST ANALYSIS BREAKDOWN

8 TECHNONLOGY ROADMAP

9 INNOVATION TRACKER AND STRATEGIC ANALYSIS

9.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS

9.1.1 JOINT VENTURES

9.1.2 MERGERS AND ACQUISITIONS

9.1.3 LICENSING AND PARTNERSHIP

9.1.4 TECHNOLOGY COLLABORATIONS

9.1.5 STRATEGIC DIVESTMENTS

9.2 NUMBER OF PRODUCTS IN DEVELOPMENT

9.3 STAGE OF DEVELOPMENT

9.4 TIMELINES AND MILESTONES

9.5 INNOVATION STRATEGIES AND METHODOLOGIES

9.6 RISK ASSESSMENT AND MITIGATION

9.7 FUTURE OUTLOOK

10 REGULATORY COMPLIANCE

10.1 REGULATORY AUTHORITIES

10.2 REGULATORY CLASSIFICATIONS

10.3 REGULATORY SUBMISSIONS

10.4 INTERNATIONAL HARMONIZATION

10.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS

10.6 REGULATORY CHALLENGES AND STRATEGIES

11 REIMBURSEMENT FRAMEWORK

12 VALUE CHAIN ANALYSIS

13 HEALTHCARE ECONOMY

13.1 HEALTHCARE EXPENDITURE

13.2 CAPITAL EXPENDITURE

13.3 CAPEX TRENDS

13.4 CAPEX ALLOCATION

13.5 FUNDING SOURCES

13.6 INDUSTRY BENCHMARKS

13.7 GDP RATION IN OVERALL GDP

13.8 HEALTHCARE SYSTEM STRUCTURE

13.9 GOVERNMENT POLICIES

13.1 ECONOMIC DEVELOPMENT

14 MIDDLE EAST AND AFRICA (MEA)TRAUMA DEVICES MARKET, BY PRODUCT TYPE

14.1 OVERVIEW

NOTE: MARKET VALUE, VOLUME AND ASP ANALYSIS WOULD BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS OF PRODUCT)

14.2 CORE TRAUMA DEVICES

14.2.1 INTERNAL FIXATOR DEVICES

14.2.1.1. SCREW

14.2.1.1.1. BY TYPE

14.2.1.1.1.1 COMPRESSION BONE SCREWS

14.2.1.1.1.1.1. MARKET VALUE (USD MILLION)

14.2.1.1.1.1.2. MARKET VOLUME (UNITS)

14.2.1.1.1.1.3. AVERAGE SELLING PRICE (USD)

14.2.1.1.1.2 ARTHRODESIS SCREWS

14.2.1.1.1.2.1. MARKET VALUE (USD MILLION)

14.2.1.1.1.2.2. MARKET VOLUME (UNITS)

14.2.1.1.1.2.3. AVERAGE SELLING PRICE (USD)

14.2.1.1.1.3 BONE SCREW WASHERS

14.2.1.1.1.3.1. MARKET VALUE (USD MILLION)

14.2.1.1.1.3.2. MARKET VOLUME (UNITS)

14.2.1.1.1.3.3. AVERAGE SELLING PRICE (USD)

14.2.1.1.2. BY LENGTH

14.2.1.1.2.1 1.5 MM

14.2.1.1.2.2 2 MM

14.2.1.1.2.3 2.7 MM

14.2.1.1.2.4 3.5 MM

14.2.1.1.2.5 OTHERS

14.2.1.1.3. BY MATERIAL

14.2.1.1.3.1 BIOABSORBABLE SCREWS

14.2.1.1.3.2 NON- BIOABSORBABLE SCREWS

14.2.1.1.4. OTHERS

14.2.1.2. NAILING

14.2.1.2.1. TIBIA NAILING SYSTEM

14.2.1.2.1.1 MARKET VALUE (USD MILLION)

14.2.1.2.1.2 MARKET VOLUME (UNITS)

14.2.1.2.1.3 AVERAGE SELLING PRICE (USD)

14.2.1.2.2. FEMUR NAILING SYSTEM

14.2.1.2.2.1 MARKET VALUE (USD MILLION)

14.2.1.2.2.2 MARKET VOLUME (UNITS)

14.2.1.2.2.3 AVERAGE SELLING PRICE (USD)

14.2.1.2.3. OTHERS

14.2.1.2.3.1 MARKET VALUE (USD MILLION)

14.2.1.2.3.2 MARKET VOLUME (UNITS)

14.2.1.2.3.3 AVERAGE SELLING PRICE (USD)

14.2.1.3. PLATES

14.2.1.3.1. COMPRESSION PLATES

14.2.1.3.1.1 MARKET VALUE (USD MILLION)

14.2.1.3.1.2 MARKET VOLUME (UNITS)

14.2.1.3.1.3 AVERAGE SELLING PRICE (USD)

14.2.1.3.2. OSTEOTOMY PLATES

14.2.1.3.2.1 MARKET VALUE (USD MILLION)

14.2.1.3.2.2 MARKET VOLUME (UNITS)

14.2.1.3.2.3 AVERAGE SELLING PRICE (USD)

14.2.1.3.3. ARTHRODESIS PLATES

14.2.1.3.3.1 MARKET VALUE (USD MILLION)

14.2.1.3.3.2 MARKET VOLUME (UNITS)

14.2.1.3.3.3 AVERAGE SELLING PRICE (USD)

14.2.1.3.4. OTHERS

14.2.1.4. STAPLES

14.2.1.4.1. MARKET VALUE (USD MILLION)

14.2.1.4.2. MARKET VOLUME (UNITS)

14.2.1.4.3. AVERAGE SELLING PRICE (USD)

14.2.1.5. WIRES

14.2.1.5.1. MARKET VALUE (USD MILLION)

14.2.1.5.2. MARKET VOLUME (UNITS)

14.2.1.5.3. AVERAGE SELLING PRICE (USD)

14.2.1.6. RODS & PINS

14.2.1.6.1. MARKET VALUE (USD MILLION)

14.2.1.6.2. MARKET VOLUME (UNITS)

14.2.1.6.3. AVERAGE SELLING PRICE (USD)

14.2.1.7. OTHERS

14.2.2 EXTERNAL FIXATOR DEVICES

14.2.2.1. UNILATERAL & BILATERAL EXTERNAL FIXATORS

14.2.2.1.1. MARKET VALUE (USD MILLION)

14.2.2.1.2. MARKET VOLUME (UNITS)

14.2.2.1.3. AVERAGE SELLING PRICE (USD)

14.2.2.2. CIRCULAR FIXATORS

14.2.2.2.1. MARKET VALUE (USD MILLION)

14.2.2.2.2. MARKET VOLUME (UNITS)

14.2.2.2.3. AVERAGE SELLING PRICE (USD)

14.2.2.3. HYBRID FIXATORS

14.2.2.3.1. MARKET VALUE (USD MILLION)

14.2.2.3.2. MARKET VOLUME (UNITS)

14.2.2.3.3. AVERAGE SELLING PRICE (USD)

14.2.2.3.4. OTHERS

14.2.3 INTRAOSSEOUS DEVICES

14.2.3.1. MANUAL

14.2.3.1.1. MARKET VALUE (USD MILLION)

14.2.3.1.2. MARKET VOLUME (UNITS)

14.2.3.1.3. AVERAGE SELLING PRICE (USD)

14.2.3.2. SEMI-AUTOMATED

14.2.3.2.1. MARKET VALUE (USD MILLION)

14.2.3.2.2. MARKET VOLUME (UNITS)

14.2.3.2.3. AVERAGE SELLING PRICE (USD)

14.2.3.3. AUTOMATED

14.2.3.3.1. MARKET VALUE (USD MILLION)

14.2.3.3.2. MARKET VOLUME (UNITS)

14.2.3.3.3. AVERAGE SELLING PRICE (USD)

14.3 SHOULDER ARTHROPLASTY DEVICES

14.3.1 BY TYPE

14.3.1.1. SHOULDER ARTHROPLASTY RESURFACING IMPLANTS

14.3.1.1.1. RESURFACING HEAD

14.3.1.1.1.1 MARKET VALUE (USD MILLION)

14.3.1.1.1.2 MARKET VOLUME (UNITS)

14.3.1.1.1.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.2. SHOULDER CUP

14.3.1.1.2.1 MARKET VALUE (USD MILLION)

14.3.1.1.2.2 MARKET VOLUME (UNITS)

14.3.1.1.2.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.3. HUMERAL STEM

14.3.1.1.3.1 MARKET VALUE (USD MILLION)

14.3.1.1.3.2 MARKET VOLUME (UNITS)

14.3.1.1.3.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.4. ECCENTER

14.3.1.1.4.1 MARKET VALUE (USD MILLION)

14.3.1.1.4.2 MARKET VOLUME (UNITS)

14.3.1.1.4.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.5. GLENOID

14.3.1.1.5.1 MARKET VALUE (USD MILLION)

14.3.1.1.5.2 MARKET VOLUME (UNITS)

14.3.1.1.5.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.6. SHELL SCREWS

14.3.1.1.6.1 MARKET VALUE (USD MILLION)

14.3.1.1.6.2 MARKET VOLUME (UNITS)

14.3.1.1.6.3 AVERAGE SELLING PRICE (USD)

14.3.1.1.7. OTHER

14.3.1.2. SHOULDER ARTHROPLASTY TRAUMA DEVICES

14.3.1.2.1. STEM INSTRUMENTS

14.3.1.2.1.1 MARKET VALUE (USD MILLION)

14.3.1.2.1.2 MARKET VOLUME (UNITS)

14.3.1.2.1.3 AVERAGE SELLING PRICE (USD)

14.3.1.2.2. PRESS INSTRUMENTS

14.3.1.2.2.1 MARKET VALUE (USD MILLION)

14.3.1.2.2.2 MARKET VOLUME (UNITS)

14.3.1.2.2.3 AVERAGE SELLING PRICE (USD)

14.3.1.2.3. GLENOID INSERTION INSTRUMENTS

14.3.1.2.3.1 MARKET VALUE (USD MILLION)

14.3.1.2.3.2 MARKET VOLUME (UNITS)

14.3.1.2.3.3 AVERAGE SELLING PRICE (USD)

14.3.1.2.4. OTHER

14.3.1.3. SHOULDER ARTHROPLASTY PLATFORM SYSTEMS

14.3.2 BY PROCEDURE

14.3.2.1. PARTIAL SHOULDER ARTHROPLASTY

14.3.2.1.1. PARTIAL RESURFACING

14.3.2.1.2. HEMI RESURFACING

14.3.2.1.3. PARTIAL-MID HEAD

14.3.2.1.4. STEMMED HEMI

14.3.2.2. TOTAL SHOULDER ARTHROPLASTY

14.3.2.2.1. TOTAL-MID HEAD

14.3.2.2.2. TOTAL CONVENTIONAL

14.3.2.2.3. TOTAL REVERSE

14.3.2.3. REVIION SHOULDER ARTHROPLASTY

14.4 FOOT AND ANKLE ARTHROPLASTY DEVICES

14.4.1 INTERANL FIXATION DEVICES

14.4.1.1. PLATES

14.4.1.1.1. MARKET VALUE (USD MILLION)

14.4.1.1.2. MARKET VOLUME (UNITS)

14.4.1.1.3. AVERAGE SELLING PRICE (USD)

14.4.1.2. SCREW

14.4.1.2.1. MARKET VALUE (USD MILLION)

14.4.1.2.2. MARKET VOLUME (UNITS)

14.4.1.2.3. AVERAGE SELLING PRICE (USD)

14.4.1.3. FUSION NAILS

14.4.1.3.1. MARKET VALUE (USD MILLION)

14.4.1.3.2. MARKET VOLUME (UNITS)

14.4.1.3.3. AVERAGE SELLING PRICE (USD)

14.4.1.4. WIRE & PINS

14.4.1.4.1. MARKET VALUE (USD MILLION)

14.4.1.4.2. MARKET VOLUME (UNITS)

14.4.1.4.3. AVERAGE SELLING PRICE (USD)

14.4.1.5. INTRAMEDULLARY IMPLANT

14.4.1.5.1. MARKET VALUE (USD MILLION)

14.4.1.5.2. MARKET VOLUME (UNITS)

14.4.1.5.3. AVERAGE SELLING PRICE (USD)

14.4.1.6. HAMMERTOE FIXATION SYSTEM

14.4.1.6.1. MARKET VALUE (USD MILLION)

14.4.1.6.2. MARKET VOLUME (UNITS)

14.4.1.6.3. AVERAGE SELLING PRICE (USD)

14.4.1.7. STAPLE FIXATION SYSTEM

14.4.1.7.1. MARKET VALUE (USD MILLION)

14.4.1.7.2. MARKET VOLUME (UNITS)

14.4.1.7.3. AVERAGE SELLING PRICE (USD)

14.4.1.8. OTHER

14.4.2 EXTERNAL FIXATION DEVICES

14.4.2.1. RING ANKLE FIXATORS

14.4.2.1.1. MARKET VALUE (USD MILLION)

14.4.2.1.2. MARKET VOLUME (UNITS)

14.4.2.1.3. AVERAGE SELLING PRICE (USD)

14.4.2.2. UNILATERAL FIXATORS

14.4.2.2.1. MARKET VALUE (USD MILLION)

14.4.2.2.2. MARKET VOLUME (UNITS)

14.4.2.2.3. AVERAGE SELLING PRICE (USD)

14.4.2.3. HYBRID FIXATORS

14.4.2.3.1. MARKET VALUE (USD MILLION)

14.4.2.3.2. MARKET VOLUME (UNITS)

14.4.2.3.3. AVERAGE SELLING PRICE (USD)

14.4.2.4. OTEHR

14.4.3 JOINT IMPLANT

14.4.3.1. ANKLE IMPLANT

14.4.3.1.1. MARKET VALUE (USD MILLION)

14.4.3.1.2. MARKET VOLUME (UNITS)

14.4.3.1.3. AVERAGE SELLING PRICE (USD)

14.4.3.2. SUBTALAR JOINT IMPLANT

14.4.3.2.1. MARKET VALUE (USD MILLION)

14.4.3.2.2. MARKET VOLUME (UNITS)

14.4.3.2.3. AVERAGE SELLING PRICE (USD)

14.4.3.3. PHALANGEAL IMPLANTS

14.4.3.3.1. MARKET VALUE (USD MILLION)

14.4.3.3.2. MARKET VOLUME (UNITS)

14.4.3.3.3. AVERAGE SELLING PRICE (USD)

14.4.3.4. OTHER

14.4.4 PROSTHESES

14.4.4.1. SOLID ANKLE CUSHION HEEL PROSTHESES

14.4.4.1.1. MARKET VALUE (USD MILLION)

14.4.4.1.2. MARKET VOLUME (UNITS)

14.4.4.1.3. AVERAGE SELLING PRICE (USD)

14.4.4.2. SINGLE ANKLE PROSTHESES

14.4.4.2.1. MARKET VALUE (USD MILLION)

14.4.4.2.2. MARKET VOLUME (UNITS)

14.4.4.2.3. AVERAGE SELLING PRICE (USD)

14.4.4.3. MULTIAXIAL PROSTHESES

14.4.4.3.1. MARKET VALUE (USD MILLION)

14.4.4.3.2. MARKET VOLUME (UNITS)

14.4.4.3.3. AVERAGE SELLING PRICE (USD)

14.4.4.4. DYNAMIC RESPONSE ENERGY STORING PROSTHESES

14.4.4.4.1. MARKET VALUE (USD MILLION)

14.4.4.4.2. MARKET VOLUME (UNITS)

14.4.4.4.3. AVERAGE SELLING PRICE (USD)

14.4.4.5. MICROPROCESSOR CONTROLLED PROSTHESES

14.5 BIOLOGICS

14.5.1 BONE GRFTS

14.5.1.1. ALLOGRAFT

14.5.1.1.1. DEMINERALIZED BONE MATRIX

14.5.1.1.1.1 MARKET VALUE (USD MILLION)

14.5.1.1.1.2 MARKET VOLUME (UNITS)

14.5.1.1.1.3 AVERAGE SELLING PRICE (USD)

14.5.1.1.2. VIABLE BONE MATRIX

14.5.1.1.2.1 MARKET VALUE (USD MILLION)

14.5.1.1.2.2 MARKET VOLUME (UNITS)

14.5.1.1.2.3 AVERAGE SELLING PRICE (USD)

14.5.1.1.3. OTHER

14.5.1.2. SYNTHETIC

14.5.1.2.1. CERAMICS

14.5.1.2.1.1 HAP

14.5.1.2.1.1.1. MARKET VALUE (USD MILLION)

14.5.1.2.1.1.2. MARKET VOLUME (UNITS)

14.5.1.2.1.1.3. AVERAGE SELLING PRICE (USD)

14.5.1.2.1.2 Β-TCP

14.5.1.2.1.2.1. MARKET VALUE (USD MILLION)

14.5.1.2.1.2.2. MARKET VOLUME (UNITS)

14.5.1.2.1.2.3. AVERAGE SELLING PRICE (USD)

14.5.1.2.1.3 Α-TCP

14.5.1.2.1.3.1. MARKET VALUE (USD MILLION)

14.5.1.2.1.3.2. MARKET VOLUME (UNITS)

14.5.1.2.1.3.3. AVERAGE SELLING PRICE (USD)

14.5.1.2.1.4 BI-PHASIC CALCIUM PHOSPHATES (BCP)

14.5.1.2.1.4.1. MARKET VALUE (USD MILLION)

14.5.1.2.1.4.2. MARKET VOLUME (UNITS)

14.5.1.2.1.4.3. AVERAGE SELLING PRICE (USD)

14.5.1.2.1.5 OTHERS

14.5.1.2.2. COMPOSITES

14.5.1.2.2.1 MARKET VALUE (USD MILLION)

14.5.1.2.2.2 MARKET VOLUME (UNITS)

14.5.1.2.2.3 AVERAGE SELLING PRICE (USD)

14.5.1.2.3. POLYMERS

14.5.1.2.3.1 MARKET VALUE (USD MILLION)

14.5.1.2.3.2 MARKET VOLUME (UNITS)

14.5.1.2.3.3 AVERAGE SELLING PRICE (USD)

14.5.1.2.4. BONE MORPHOGENIC PROTEINS (BMP)

14.5.1.2.4.1 MARKET VALUE (USD MILLION)

14.5.1.2.4.2 MARKET VOLUME (UNITS)

14.5.1.2.4.3 AVERAGE SELLING PRICE (USD)

14.5.1.2.5. OTHER

14.5.2 ACELLULAR DERMAL MATRIX

14.5.2.1. MARKET VALUE (USD MILLION)

14.5.2.2. MARKET VOLUME (UNITS)

14.5.2.3. AVERAGE SELLING PRICE (USD)

14.5.3 ALLOGRAFT BONE WEDGE

14.5.3.1. UNICORTAL

14.5.3.1.1. MARKET VALUE (USD MILLION)

14.5.3.1.2. MARKET VOLUME (UNITS)

14.5.3.1.3. AVERAGE SELLING PRICE (USD)

14.5.3.2. TRICORTAL

14.5.3.2.1. MARKET VALUE (USD MILLION)

14.5.3.2.2. MARKET VOLUME (UNITS)

14.5.3.2.3. AVERAGE SELLING PRICE (USD)

14.5.4 NERVE CONDUIT & WRAPS

14.5.4.1. MARKET VALUE (USD MILLION)

14.5.4.2. MARKET VOLUME (UNITS)

14.5.4.3. AVERAGE SELLING PRICE (USD)

14.5.5 SHAFT

14.5.5.1. MARKET VALUE (USD MILLION)

14.5.5.2. MARKET VOLUME (UNITS)

14.5.5.3. AVERAGE SELLING PRICE (USD)

14.5.6 CHIPS

14.5.6.1. MARKET VALUE (USD MILLION)

14.5.6.2. MARKET VOLUME (UNITS)

14.5.6.3. AVERAGE SELLING PRICE (USD)

14.5.7 OTHER

14.6 OTHER

14.6.1 BONE ADHESIVES

14.6.1.1. BONE CEMENT

14.6.1.1.1. BY TYPE

14.6.1.1.1.1 POLYMETHYL METHACRYLATE (PMMA) CEMENT

14.6.1.1.1.1.1. MARKET VALUE (USD MILLION)

14.6.1.1.1.1.2. MARKET VOLUME (UNITS)

14.6.1.1.1.1.3. AVERAGE SELLING PRICE (USD)

14.6.1.1.1.2 CALCIUM PHOSPHATE CEMENT (CPC)

14.6.1.1.1.2.1. MARKET VALUE (USD MILLION)

14.6.1.1.1.2.2. MARKET VOLUME (UNITS)

14.6.1.1.1.2.3. AVERAGE SELLING PRICE (USD)

14.6.1.1.1.3 GLASS POLYALKENOATE CEMENT (GPC)

14.6.1.1.1.3.1. MARKET VALUE (USD MILLION)

14.6.1.1.1.3.2. MARKET VOLUME (UNITS)

14.6.1.1.1.3.3. AVERAGE SELLING PRICE (USD)

14.6.1.1.1.4 OTHERS

14.6.1.1.2. BY LOADING

14.6.1.1.2.1 ANTIBIOTIC-LOADED BONE CEMENT

14.6.1.1.2.2 NON-ANTIBIOTIC-LOADED BONE CEMENT

14.6.1.2. BONE GLUE

14.6.1.2.1. NATURAL BONE GLUE

14.6.1.2.1.1 MARKET VALUE (USD MILLION)

14.6.1.2.1.2 MARKET VOLUME (UNITS)

14.6.1.2.1.3 AVERAGE SELLING PRICE (USD)

14.6.1.2.2. SYNTHETIC BONE GLUE

14.6.1.2.2.1 MARKET VALUE (USD MILLION)

14.6.1.2.2.2 MARKET VOLUME (UNITS)

14.6.1.2.2.3 AVERAGE SELLING PRICE (USD)

15 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY MATERIAL

15.1 OVERVIEW

15.2 BIO-ABSORBABLE

15.2.1 OLYLACTIC ACID POLYMER

15.2.2 POLYGLYCOLIC ACID POLYMERS

15.2.3 OTHERS

15.3 NON- ABSORBABLE

15.3.1 TITANIUM

15.3.2 STAINLESS STEEL

15.3.3 OTHERS

16 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY SURGICAL SITE

16.1 OVERVIEW

16.2 UPPER EXTRIMITIES

16.2.1 SHOULDER

16.2.2 HAND AND WRIST

16.2.3 MAXILLOFACIAL

16.2.4 ELBOW

16.2.5 ARM

16.2.6 OTHERS

16.3 LOWER EXTREMETIES

16.3.1 HIP

16.3.2 THIGH

16.3.3 KNEE

16.3.4 LEG

16.3.5 ANKLE

16.3.6 FOOT

16.3.7 OTHERS

17 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY TRAUMA TYPE

17.1 OVERVIEW

17.2 DISLOCATIONS

17.3 JOINT REPLACEMENT AND FRACTURES

17.4 NERVE DISEASES AND SOFT TISSUE INJURIES

17.5 OTHERS

18 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY PATIENT TYPE

18.1 OVERVIEW

18.2 PEDIATRIC

18.2.1 MALE

18.2.2 FEMALE

18.3 ADULT

18.3.1 MALE

18.3.2 FEMALE

18.4 GERIATRIC

18.4.1 MALE

18.4.2 FEMALE

19 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY END USER

19.1 OVERVIEW

19.2 HOSPITALS

19.2.1 BY TYPE

19.2.1.1. PUBLIC

19.2.1.2. PRIVATE

19.2.2 BY TIER

19.2.2.1. TIER 1

19.2.2.2. TIER 2

19.2.2.3. TIER 3

19.3 TRAUMA CENTRES

19.4 AMBULATORY SURGICAL CENTRES

19.5 SPECIALITY CLINICS

19.6 OTHER

20 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY DISTRIBUTION CHANNEL

20.1 OVERVIEW

20.2 DIRECT TENDERS

20.3 RETAIL SALES

20.3.1 ONLINE SALES

20.3.2 OFFLINE SALES

20.4 OTHERS

21 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, SWOT AND DBMR ANALYSIS

22 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, COMPANY LANDSCAPE

22.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)

22.2 MERGERS & ACQUISITIONS

22.3 NEW PRODUCT DEVELOPMENT & APPROVALS

22.4 EXPANSIONS

22.5 REGULATORY CHANGES

22.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

23 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY REGION

MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

23.1 MIDDLE EAST AND AFRICA

23.1.1 SOUTH AFRICA

23.1.2 EGYPT

23.1.3 BAHRAIN

23.1.4 UNITED ARAB EMIRATES

23.1.5 KUWAIT

23.1.6 OMAN

23.1.7 QATAR

23.1.8 SAUDI ARABIA

23.1.9 REST OF MEA

23.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

24 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, COMPANY PROFILE

24.1 GLOBAL COMPANIES

24.1.1 STRYKER

24.1.1.1. COMPANY OVERVIEW

24.1.1.2. REVENUE ANALYSIS

24.1.1.3. GEOGRAPHIC PRESENCE

24.1.1.4. PRODUCT PORTFOLIO

24.1.1.5. RECENT DEVELOPMENTS

24.1.2 DEPUY SYNTHES(JOHNSON & JOHNSON)

24.1.2.1. COMPANY OVERVIEW

24.1.2.2. REVENUE ANALYSIS

24.1.2.3. GEOGRAPHIC PRESENCE

24.1.2.4. PRODUCT PORTFOLIO

24.1.2.5. RECENT DEVELOPMENTS

24.1.3 ZIMMER BIOMET

24.1.3.1. COMPANY OVERVIEW

24.1.3.2. REVENUE ANALYSIS

24.1.3.3. GEOGRAPHIC PRESENCE

24.1.3.4. PRODUCT PORTFOLIO

24.1.3.5. RECENT DEVELOPMENTS

24.1.4 MEDTRONICS

24.1.4.1. COMPANY OVERVIEW

24.1.4.2. REVENUE ANALYSIS

24.1.4.3. GEOGRAPHIC PRESENCE

24.1.4.4. PRODUCT PORTFOLIO

24.1.4.5. RECENT DEVELOPMENTS

24.1.5 ARTHREX, INC

24.1.5.1. COMPANY OVERVIEW

24.1.5.2. REVENUE ANALYSIS

24.1.5.3. GEOGRAPHIC PRESENCE

24.1.5.4. PRODUCT PORTFOLIO

24.1.5.5. RECENT DEVELOPMENTS

24.1.6 SMITH+NEPHEW

24.1.6.1. COMPANY OVERVIEW

24.1.6.2. REVENUE ANALYSIS

24.1.6.3. GEOGRAPHIC PRESENCE

24.1.6.4. PRODUCT PORTFOLIO

24.1.6.5. RECENT DEVELOPMENTS

24.1.7 GLOBUS MEDICAL

24.1.7.1. COMPANY OVERVIEW

24.1.7.2. REVENUE ANALYSIS

24.1.7.3. GEOGRAPHIC PRESENCE

24.1.7.4. PRODUCT PORTFOLIO

24.1.7.5. RECENT DEVELOPMENTS

24.1.8 ORTHOMED

24.1.8.1. COMPANY OVERVIEW

24.1.8.2. REVENUE ANALYSIS

24.1.8.3. GEOGRAPHIC PRESENCE

24.1.8.4. PRODUCT PORTFOLIO

24.1.8.5. RECENT DEVELOPMENTS

24.1.9 DJO, LLC

24.1.9.1. COMPANY OVERVIEW

24.1.9.2. REVENUE ANALYSIS

24.1.9.3. GEOGRAPHIC PRESENCE

24.1.9.4. PRODUCT PORTFOLIO

24.1.9.5. RECENT DEVELOPMENTS

24.1.10 B. BRAUN SE

24.1.10.1. COMPANY OVERVIEW

24.1.10.2. REVENUE ANALYSIS

24.1.10.3. GEOGRAPHIC PRESENCE

24.1.10.4. PRODUCT PORTFOLIO

24.1.10.5. RECENT DEVELOPMENTS

24.1.11 ZIMED MEDIKAL

24.1.11.1. COMPANY OVERVIEW

24.1.11.2. REVENUE ANALYSIS

24.1.11.3. GEOGRAPHIC PRESENCE

24.1.11.4. PRODUCT PORTFOLIO

24.1.11.5. RECENT DEVELOPMENTS

24.1.12 INTEGRA LIFESCIENCES CORPORATION

24.1.12.1. COMPANY OVERVIEW

24.1.12.2. REVENUE ANALYSIS

24.1.12.3. GEOGRAPHIC PRESENCE

24.1.12.4. PRODUCT PORTFOLIO

24.1.12.5. RECENT DEVELOPMENTS

24.1.13 BIORETEC GMBH

24.1.13.1. COMPANY OVERVIEW

24.1.13.2. REVENUE ANALYSIS

24.1.13.3. GEOGRAPHIC PRESENCE

24.1.13.4. PRODUCT PORTFOLIO

24.1.13.5. RECENT DEVELOPMENTS

24.1.14 ORTHOFIX MEDICAL INC.

24.1.14.1. COMPANY OVERVIEW

24.1.14.2. REVENUE ANALYSIS

24.1.14.3. GEOGRAPHIC PRESENCE

24.1.14.4. PRODUCT PORTFOLIO

24.1.14.5. RECENT DEVELOPMENTS

24.2 LOCAL COMPANIES

24.2.1 RENISHAW PLC.

24.2.1.1. COMPANY OVERVIEW

24.2.1.2. REVENUE ANALYSIS

24.2.1.3. GEOGRAPHIC PRESENCE

24.2.1.4. PRODUCT PORTFOLIO

24.2.1.5. RECENT DEVELOPMENTS

24.2.2 TST

24.2.2.1. COMPANY OVERVIEW

24.2.2.2. REVENUE ANALYSIS

24.2.2.3. GEOGRAPHIC PRESENCE

24.2.2.4. PRODUCT PORTFOLIO

24.2.2.5. RECENT DEVELOPMENTS

24.2.3 SURGIPHARM LIMITED

24.2.3.1. COMPANY OVERVIEW

24.2.3.2. REVENUE ANALYSIS

24.2.3.3. GEOGRAPHIC PRESENCE

24.2.3.4. PRODUCT PORTFOLIO

24.2.3.5. RECENT DEVELOPMENTS

24.2.4 BAIRDMED

24.2.4.1. COMPANY OVERVIEW

24.2.4.2. REVENUE ANALYSIS

24.2.4.3. GEOGRAPHIC PRESENCE

24.2.4.4. PRODUCT PORTFOLIO

24.2.4.5. RECENT DEVELOPMENTS

24.2.5 ORTHO-SOL DEVELOPMENT (PTY) LTD

24.2.5.1. COMPANY OVERVIEW

24.2.5.2. REVENUE ANALYSIS

24.2.5.3. GEOGRAPHIC PRESENCE

24.2.5.4. PRODUCT PORTFOLIO

24.2.5.5. RECENT DEVELOPMENTS

25 REPORTS

26 CONCLUSION

27 QUESTIONNAIRE

28 ABOUT DATA BRIDGE MARKET RESEARCH